Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
about
Eradication therapy for peptic ulcer disease inHelicobacter pylori-positive peopleEradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsStandardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.Pooled analysis of Helicobacter pylori eradication regimes in Asia.Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Eradication of Helicobacter pylori: therapies and clinical implications.In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.Acute upper gastrointestinal bleeding in elderly persons.Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strainsAppearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strainsDevelopment of a 14C-urea breath test in ferrets colonised with Helicobacter mustelae: effects of treatment with bismuth, antibiotics, and urease inhibitorsImpact of metronidazole resistance on the eradication of Helicobacter pylori.
P2860
Q24185883-64A03B94-7CDC-47DB-81B4-D8303CA543A8Q24246267-6C3BA1C8-45B5-4793-B5B1-A369EDB28FA1Q33761162-A53EA35C-8B59-44B6-B8E0-2EDC43FEF5CCQ34074306-200068FC-5671-4D4E-82BD-6C7B0BF42520Q35110775-7D76BFA1-C53A-4AF3-A295-A43F105F404AQ35531059-5D201275-52F1-4312-8128-FB3E04D3B832Q35815437-05448366-0426-4BD7-BBE8-E4E7E50D4F98Q36758145-D62730A3-AC67-46E6-BD06-B1E8DD5A9CF9Q36894879-F871D59F-EBB2-44B5-8560-367BB66C6883Q37682398-DA4E2D03-33C8-4032-A7D0-EB680CE07E0EQ39779000-7C149E33-A071-4B02-BD29-506E82515B08Q39785375-B51E92AE-A457-4241-8089-2A3CF0C84787Q41955201-BE9567DF-43A9-4709-BB33-AE84CF5F81E9Q54221092-C80B0FA6-4376-4FF8-9718-4005E805999D
P2860
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@en
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@nl
type
label
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@en
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@nl
prefLabel
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@en
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@nl
P2093
P2860
P356
P1433
P1476
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
@en
P2093
O'Morain C
O'Riordan T
P2860
P304
P356
10.1136/GUT.31.9.999
P407
P577
1990-09-01T00:00:00Z